Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sleijfer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
ESMO Open|March 6, 2022
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancerN Beije, I E de Kruijff, J J de Jong, et al.
BMC Cancer|March 26, 2021
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trialE E A P Mulder, K de Joode, S Litière, et al.
Nature|October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugsD L van der Velden, L R Hoes, H van der Wijngaart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, S Bielack, N Abecassis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2021
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, J Y Blay, N Abecassis, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
ESMO Open|March 6, 2022
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancerN Beije, I E de Kruijff, J J de Jong, et al.
BMC Cancer|March 26, 2021
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trialE E A P Mulder, K de Joode, S Litière, et al.
Nature|October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugsD L van der Velden, L R Hoes, H van der Wijngaart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, S Bielack, N Abecassis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2021
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, J Y Blay, N Abecassis, et al.
Pageof 10